Formulary coverage, tier placement, and prior-authorization requirements vary by plan and are not published comprehensively at the drug level elsewhere
In the United States, the compound's unapproved status also intersects with compounding policy: the FDA has publicly categorized BPC-157 among substances it has flagged for pharmacy compounding review, reflecting the agency's position that available data are insufficient to support that use
The news: Eli Lilly is launching Lilly Employer Connect, a direct-to-employer platform for its obesity drug Zepbound, offering flat pricing for companies
Cardio-safe degrader CT-03p degrades MCL-1 and overcomes venetoclax resistance in AML
Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle
While semaglutide is not approved to treat alcohol use disorder, growing anecdotal evidence and mechanistic studies suggest a potential link between GLP-1 activation and reduced drinking behavior
